157 related articles for article (PubMed ID: 18338236)
21. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
[TBL] [Abstract][Full Text] [Related]
22. Medium-term results from the clinical and angiographic follow-up of patients after angioplasty and implantation of sirolimus-eluting stents.
Dardas PS; Tsikaderis DD; Mezilis NE; Hatzimiltiadis S
Hellenic J Cardiol; 2005; 46(2):117-23. PubMed ID: 15847131
[TBL] [Abstract][Full Text] [Related]
23. Additional value of dipyridamole stress myocardial perfusion by 64-row computed tomography in patients with coronary stents.
Magalhães TA; Cury RC; Pereira AC; Moreira Vde M; Lemos PA; Kalil-Filho R; Rochitte CE
J Cardiovasc Comput Tomogr; 2011; 5(6):449-58. PubMed ID: 22146504
[TBL] [Abstract][Full Text] [Related]
24. Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.
Freixa X; Almasood AS; Khan SQ; Wainstein R; Osherov A; Mackie K; Seidelin PH; Džavík V
Catheter Cardiovasc Interv; 2012 Mar; 79(4):559-65. PubMed ID: 21567881
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of fractional flow reserve for evaluation of functional lesion severity in stent restenosis and native coronary arteries.
Krüger S; Koch KC; Kaumanns I; Merx MW; Hanrath P; Hoffmann R
Chest; 2005 Sep; 128(3):1645-9. PubMed ID: 16162770
[TBL] [Abstract][Full Text] [Related]
26. Provisional stenting for multivessel PCI.
Han B; Liu L; Aboud M; Nahir M; Hasin Y
Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
[TBL] [Abstract][Full Text] [Related]
27. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
[TBL] [Abstract][Full Text] [Related]
28. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
[TBL] [Abstract][Full Text] [Related]
29. Comparison between four-slice computed tomography and coronary angiography for the assessment of coronary stents.
Mazzarotto P; Di Renzi P; Paluello GM; Carunchio A; Ricci R; Molisso A; Ceci V; Indolfi C
J Cardiovasc Med (Hagerstown); 2006 May; 7(5):328-34. PubMed ID: 16645410
[TBL] [Abstract][Full Text] [Related]
30. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
[TBL] [Abstract][Full Text] [Related]
31. Feasibility, safety, and efficacy of a novel polymeric pimecrolimus-eluting stent: traditional pre-clinical safety end points failed to predict 6-month clinical angiographic results.
Ormiston JA; Webster MW; Schwartz RS; Gladding P; Stewart JT; Kay IP; Ruygrok PN; Hatrick R
JACC Cardiovasc Interv; 2009 Oct; 2(10):1017-24. PubMed ID: 19850264
[TBL] [Abstract][Full Text] [Related]
32. Impact of coronary collateral circulation on angiographic in-stent restenosis in patients with stable coronary artery disease and chronic total occlusion.
Yang ZK; Shen Y; Hu J; Zhang Q; Ding FH; Zhang RY; Lu L; Shen WF
Int J Cardiol; 2017 Jan; 227():485-489. PubMed ID: 27836292
[TBL] [Abstract][Full Text] [Related]
33. Third in-stent restenosis in sirolimus eluting stents: predictors of the next restenosis.
Ozawa M; Okamura A; Date M; Higuchi Y; Nagai H; Shibuya M; Ryusuke K; Inoue K; Koyama Y; Iwakura K; Fujii K
Catheter Cardiovasc Interv; 2012 Jan; 79(1):91-6. PubMed ID: 21452246
[TBL] [Abstract][Full Text] [Related]
34. Identification of hemodynamically significant restenosis after percutaneous transluminal coronary angioplasty in acute myocardial infarction by transesophageal dobutamine stress echocardiography and comparison with myocardial single photon emission computed tomography.
Rosenkranz S; Voth E; Larosée K; Baer FM; Kettering K; Smolarz K; Moka D; Schicha H; Erdmann E; Deutsch HJ
J Interv Cardiol; 2001 Jun; 14(3):271-82. PubMed ID: 12053386
[TBL] [Abstract][Full Text] [Related]
35. Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients.
Rathore S; Terashima M; Katoh O; Matsuo H; Tanaka N; Kinoshita Y; Kimura M; Tuschikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
EuroIntervention; 2009 Aug; 5(3):349-54. PubMed ID: 19736160
[TBL] [Abstract][Full Text] [Related]
36. Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery.
Nanni S; Lovato L; Ghetti G; Vagnarelli F; Mineo G; Fattori R; Saia F; Marzocchi A; Marrozzini C; Zompatori M; Reggiani LB; Semprini F; Melandri G; Biagini E; Corsini A; Norscini G; Rapezzi C
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1589-1597. PubMed ID: 28455632
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of single-photon emission computed tomography myocardial perfusion imaging in patients with stents in native coronary arteries.
Milavetz JJ; Miller TD; Hodge DO; Holmes DR; Gibbons RJ
Am J Cardiol; 1998 Oct; 82(7):857-61. PubMed ID: 9781967
[TBL] [Abstract][Full Text] [Related]
38. Restenosis in coronary bare metal stents. Importance of time to follow-up: a comparison of coronary angiograms 6 months and 4 years after implantation.
Jørgensen E; Helqvist S; Kløvgaard L; Kastrup J; Clemmensen P; Holmvang L; Engstrøm T; Saunamaki K; Kelbaek H
Scand Cardiovasc J; 2009 Apr; 43(2):87-93. PubMed ID: 19031301
[TBL] [Abstract][Full Text] [Related]
39. Late target lesion revascularization after implantation of sirolimus-eluting stent.
Hong MK; Mintz GS; Lee CW; Park DW; Lee SW; Kim YH; Jung IH; Kim SH; Cheong SS; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Feb; 71(3):299-303. PubMed ID: 17985380
[TBL] [Abstract][Full Text] [Related]
40. Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents.
Kim JS; Lee SY; Lee JM; Yoon YW; Ahn CM; Kim MH; Min PK; Ko YG; Hong BK; Choi D; Kwon HM; Jang Y; Shim WH
Coron Artery Dis; 2009 Jan; 20(1):59-63. PubMed ID: 19008765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
